Roche to phase out microarray offering to focus on genome sequencing
13:17 EDT 20 Jun 2012 | SCRIP
Roche is planning to close down or sell off its NimbleGen microarray business, according to media reports. Roche acquired NimbleGen for $272.5 million in 2007; if true, the rumours could mean it is abandoning the microarray market to focus on the.....
Original Article: Roche to phase out microarray offering to focus on genome sequencing
More From BioPortfolio on "Roche to phase out microarray offering to focus on genome sequencing"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
